Liontrust Asset Management (LIO)
London Stock Exchange · UK · prices in GBX · close of 27 Oct 2026
Key indicators
| Last close | GBX 285.50 |
|---|---|
| 52-week range | 223.00 – 358.00 |
| Return, 1 month / 3 months | +9.0% / −1.9% |
| Return, 1 year / 3 years | −3.3% / −27.0% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 46 |
| Volatility (1 year) | 40.2% |
| Worst drawdown (1 year) | -25.5% |
| Average daily value traded | 52.42M GBX |
| Dividend yield | 6.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Liontrust Asset Management is a fund management company based in the United Kingdom. It runs actively managed investment funds across equities, fixed income and multi-asset strategies, with teams focused on specific approaches such as sustainable investment and smaller companies. Its customers include individual investors, financial advisers and institutional clients who invest through the funds it manages. The company earns its revenue from the fees charged for managing those portfolios on behalf of its clients.
The shares are listed on the London Stock Exchange in UK under the code LIO, and the price on this page is in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Liontrust Asset Management (LIO) trades on the London Stock Exchange in UK. It last closed at GBX 285.50 on 27 October 2026.
Its price-based Market X-Ray is 61 out of 100 (a fair price profile), ranking 1,265 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 3.3% and over the last three months it fell 1.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 59 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 3.2% | ||
| From 52-week high | -18.7% | ||
| Momentum | 49 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -1.9% | ||
| 6-month return | 11.1% | ||
| 12-month return, skipping the last month | -11.2% | ||
| Stability (higher is calmer) | 50 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 40.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -25.5% | ||
| Liquidity | 85 · Strong | Trades actively. | |
| Average daily value traded | 52.42M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 86 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 6.7% | ||
| Years with dividends | 6 |
Strengths
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −3.2% |
|---|---|
| 1 month | +9.0% |
| 3 months | −1.9% |
| 6 months | +11.1% |
| 1 year | −3.3% |
| 3 years | −27.0% |
| 5 years | −77.9% |
Signals
| 50-day / 200-day average | 292.77 / 276.66 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 14.22 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 2 Jul 2026 | GBP 0.1200 |
| 27 Nov 2025 | GBP 0.0700 |
| 3 Jul 2025 | GBP 0.5000 |
| 28 Nov 2024 | GBP 0.2200 |
| 4 Jul 2024 | GBP 0.5000 |
| 23 Nov 2023 | GBP 0.2200 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.